삼성바이오로직스

207940 코스피
1,410,000 39,000 (-2.69%)
기준 : 11/13 16:55
  • 시가총액
    685,195억
  • 주식수
    4,668만
  • PER
    34.53배
  • PBR
    8.19배
  • ROE
    23.73%
  • 결산월
    12월

26.3Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2026/09 2026/06 2026/03 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09 2016/06 2016/03 2015/12 2015/09 2015/06 2015/03 2014/12 2014/09 2014/06 2014/03 2013/12 2013/09 2013/06 2013/03 2012/12 2012/09
매출액(수익) 53,54053,540.2 51,21251,212.1 48,14548,145.4 45,56945,569.7 44,54644,546.6
내수 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 51,21251,212.1 48,14548,145.4 45,56945,569.7 44,54644,546.6
매출원가 N/AN/A 23,32923,329.5 21,59921,599.8 20,40320,403.3 19,34919,349.1
원재료 N/AN/A 10,15010,150.2 9,8219,821.7 8,9738,973.2 8,8368,836.0
재고자산의변동 N/AN/A -3,317-3,317.4 -2,928-2,928.9 -2,157-2,157.6 -3,028-3,028.3
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 6,1646,164.7 5,8205,820.0 5,5935,593.6 5,4265,426.1
감가상각비 N/AN/A 3,4473,447.4 3,3633,363.5 3,2773,277.0 3,3193,319.0
기타 N/AN/A 6,8846,884.5 5,5235,523.5 4,7174,717.0 4,7964,796.2
매출총이익 N/AN/A 27,88227,882.6 26,54526,545.5 25,16625,166.4 25,19725,197.5
판매비와관리비 N/AN/A 4,5924,592.9 4,3484,348.2 4,4744,474.1 5,0165,016.3
급여 N/AN/A 1,3971,397.4 1,4141,414.8 1,4561,456.7 1,3201,320.5
퇴직급여 N/AN/A 115115.0 105105.4 7676.0 7878.1
복리후생비 N/AN/A 354354.9 348348.6 343343.4 335335.1
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A 2020.7 2020.3 1919.9 1818.5
전산처리비 N/AN/A 136136.0 106106.5 119119.5 338338.4
지급수수료 N/AN/A 1,0021,002.4 909909.9 1,0251,025.3 1,2211,221.1
용역비 N/AN/A N/AN/A N/AN/A N/AN/A 22.0
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 7474.1 7070.5 6666.1 6666.5
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 372372.3 368368.3 371371.8 658658.1
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A -1-1.6 -62-62.8 -8-8.1 -42-42.1
감가상각비 N/AN/A 201201.9 196196.5 182182.2 173173.5
무형자산상각비 N/AN/A 143143.1 142142.8 137137.9 137137.0
기타 N/AN/A 776776.4 727727.2 683683.0 709709.2
영업이익 23,35523,355.0 23,28923,289.7 22,19722,197.3 20,69220,692.2 20,18120,181.1
EBITDA N/AN/A 29,42229,422.7 28,65228,652.6 27,35427,354.0 27,29227,292.6
금융손익 N/AN/A 1,2461,246.4 781781.1 9494.1 258258.8
금융수익 N/AN/A 1,9651,965.9 1,9661,966.9 1,5071,507.8 1,7331,733.8
이자수익 N/AN/A 513513.3 485485.7 460460.3 432432.2
외환거래이익 N/AN/A 1,4521,452.6 1,4811,481.1 1,0471,047.4 1,2871,287.7
외환차익 N/AN/A 1,0921,092.8 1,0131,013.5 949949.0 945945.1
외화환산이익 N/AN/A 359359.8 467467.6 9898.4 342342.6
기타 N/AN/A N/AN/A 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A 55.3
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A 88.5
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 719719.4 1,1851,185.8 1,4131,413.6 1,4741,474.9
이자비용 N/AN/A 325325.4 289289.2 291291.7 370370.2
외환거래손실 N/AN/A 392392.1 896896.5 1,1211,121.9 1,1361,136.5
외환차손 N/AN/A 557557.6 720720.2 968968.8 1,0771,077.8
외화환산손실 N/AN/A -165-165.5 176176.3 153153.0 5858.7
기타 N/AN/A 00.0 00.0 00.0 00.0
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A -31-31.8
기타 N/AN/A 11.9 00.0 00.0 00.0
기타영업외손익 N/AN/A 7575.6 22.1 -30-30.9 2020.3
기타영업외수익 N/AN/A 168168.3 9090.2 7272.8 100100.3
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A 00.0 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 55.9 55.9 55.9 55.8
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 22.0 33.1 88.1 88.4
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 160160.2 8181.0 5858.7 8585.9
기타영업외비용 N/AN/A 9292.7 8888.0 103103.8 8080.0
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 3232.6 3434.1 4040.6 3636.9
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 5959.2 5353.3 6262.5 3232.1
무형자산처분손실 N/AN/A 00.8 00.0 00.0 00.0
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A N/AN/A 66.8
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.1 00.6 00.5 44.1
종속기업및관계기업관련손익 N/AN/A 1212.0 220220.5 430430.8 180180.9
지분법손익 N/AN/A 1212.0 220220.5 430430.8 180180.9
지분법이익 N/AN/A 276276.5 271271.7 430430.8 179179.0
지분법손실 N/AN/A -264-264.5 -51-51.1 N/AN/A 11.8
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 1212.0 220220.5 N/AN/A 11.8
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A 24,62324,623.8 23,20123,201.2 21,18621,186.3 20,64120,641.2
법인세비용 N/AN/A 6,1306,130.5 5,6785,678.8 5,0435,043.0 5,1125,112.4
중단사업이익 N/AN/A 1,3491,349.8 1,2581,258.0 1,7001,700.2 430430.1
당기순이익 17,44017,440.9 19,84319,843.1 18,78018,780.4 17,84317,843.5 15,95815,958.9
지배지분 순이익 N/AN/A 19,84319,843.1 18,78018,780.4 17,84317,843.5 15,95815,958.9
비지배지분 순이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익 N/AN/A 7373.4 -27-27.9 -53-53.9 -80-80.2
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A 135135.0 3030.0 0-0.9 3535.2
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -61-61.6 -57-57.9 -52-52.9 -115-115.4
총포괄이익 N/AN/A 19,91619,916.5 18,75218,752.5 17,78917,789.5 15,87815,878.6
지배지분 총포괄이익 N/AN/A 19,91619,916.5 18,75218,752.5 17,78917,789.5 15,87815,878.6
비지배지분 총포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
주당순이익 N/AN/A 36,44036,440.2 31,73431,734.3 26,91426,914.5 22,23522,235.3
시가총액 N/AN/A 643,907643,907.1 696,215696,215.9 784,631784,631.6 709,604709,604.7
주가 N/AN/A 1,380,2931,380,293.0 1,492,4231,492,423.0 1,681,9531,681,953.0 1,456,0331,456,033.0
주가수익배수 N/AN/A 32.4532.45 37.0737.07 43.9743.97 44.4644.46
주식수(만주) N/A 4,668 4,668 4,668 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 7,177 6,752 6,752 6,752 6,752 6,752 6,752 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄